Novelos Therapeutics Inc

Entity type image
Type: Company
Name: Novelos Therapeutics Inc
First reported May 29 2013 - Updated May 30 2013 - 1 reports

Novelos Therapeutics, Inc. Files SEC Form 424B3, Prospectus . . .

Novelos Therapeutics, Inc. Files SEC Form 424B3, Prospectus [Rule 424(B)(3)] (May. 16, 2013)Pharmaceutical PreparationsNewsRx.comBy a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., ... [Published Equities.com - May 29 2013]

More Content

All (14) | News (9) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (5)
sort by: Date | Relevance
Novelos Therapeutics, Inc. Files SEC Form 424B3... [Published Equities.com - May 29 2013]
Novelos Therapeutics, Inc. (NVLT) - Pharmaceuti... [Published TransWorldNews - May 21 2013]
Novelos Therapeutics Provides Product Pipeline ... [Published PR Newswire: Financial Services - May 16 2013]
8-K - NOVELOS THERAPEUTICS, INC. (0001279704) (... [Published SEC Filings - Feb 21 2013]
Novelos Therapeutics Closes $5.5 Million Public... [Published PR Newswire: Financial Services - Feb 21 2013]
8-K - NOVELOS THERAPEUTICS, INC. (0001279704) (... [Published SEC Filings - Feb 14 2013]
Novelos Therapeutics Prices $5.5 Million Public... [Published PR Newswire: Financial Services - Feb 13 2013]
Novelos Therapeutics To Present At The 15th Ann... [Published Financial Services - Feb 04 2013]
Novelos Therapeutics Presents Diapeutic Technol... [Published PR Newswire: Financial Services - Jan 31 2013]
8-K - NOVELOS THERAPEUTICS, INC. (0001279704) (... [Published SEC Filings - Dec 19 2012]
8-K - NOVELOS THERAPEUTICS, INC. (0001279704) (... [Published SEC Filings - Oct 26 2012]
UWCCC enrolls first patient in Phase 12 PET ima... [Published BioPortfolio - Oct 26 2012]
Novelos completes phase I b dose-escalation tri... [Published PharmaBiz - Sep 13 2012]
8-K - NOVELOS THERAPEUTICS, INC. (0001279704) (... [Published SEC Filings - Sep 12 2012]
1
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
Novelos Therapeutics Provides Product Pipeline ... [Published PR Newswire: Financial Services - May 16 2013]
Novelos Therapeutics Closes $5.5 Million Public... [Published PR Newswire: Financial Services - Feb 21 2013]
Novelos Therapeutics Prices $5.5 Million Public... [Published PR Newswire: Financial Services - Feb 13 2013]
Novelos Therapeutics To Present At The 15th Ann... [Published Financial Services - Feb 04 2013]
Novelos Therapeutics Presents Diapeutic Technol... [Published PR Newswire: Financial Services - Jan 31 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.